Research Newsletter - January 2023

News briefs | January 2023

NCCN update: Haywood joins NCCN DEI Directors Forum

Haywood

The National Comprehensive Cancer Network’s new Diversity, Equity, & Inclusion (DEI) Directors Forum is working together to improve the diversity of clinical staff representation across the nation’s leading academic cancer centers. Antwione M. Haywood, Ph.D., associate director of diversity, equity, and inclusion at the cancer center, is among the experts on DEI in health care named to the forum. The NCCN DEI Directors Forum will provide a venue to share challenges and best practices in advancing DEI initiatives in a timely fashion. Read the NCCN’s announcement.

Upcoming events

Offered by Healthy IU, a panel of experts will present Prostate Cancer Prevention 101: Take Charge of Your Health at noon Wednesday, Feb. 22. As part of IU’s workplace wellness program, the webinar is for IU employees, spouses on an IU medical plan and retirees. Panelists include Mary Robertson, MPH, prevention and screening program leader with the cancer center’s Office of Community Outreach and Engagement, and Michael Koch, M.D., cancer center member and chair and professor, Department of Urology, IU School of Medicine. Learn more and register.

The next Simon Says Expert Series will be at noon Feb. 28, focused on supporting family caregivers. Catherine Mosher, Ph.D., and Kristin Levoy, Ph.D., MSN, will present; Shelley Johns, Psy.D., will serve as moderator. More details and registration will be available soon.

ICYMI: Check out the latest content on the cancer center’s social media channels

Check out the latest airport ads featuring Jodi Skiles, M.D., and Rich Zellars, M.D., in this Twitter post.

Francesca Duncan, M.D., presented this month’s Simon Says Expert Series, “Health Disparities Across the Lung Cancer Continuum,” with Lauren Nephew, M.D., moderating. The session was streamed live on Facebook.

Watch a highlight reel on Instagram of End Lung Cancer Now at IUPUI’s Weeks of Welcome. During the event, 44 students signed the #WeCanBeTheFirst pledge to promote, encourage, and support college students to become the first tobacco-free generation.

Read on LinkedIn the Inside Indiana Business story about the cancer center’s new translational cancer biology Ph.D. program.

Member headlines and highlights

Robb Lautenschlaeger	Sheri Robb, Ph.D. (CPC), appeared on Inside Indiana Business to discuss how music therapy can improve health outcomes for kids with cancer and their parents. Watch the story.
	Melissa Fishel, Ph.D. (TMM), Mark Kelley, Ph.D. (EDT), and colleagues wrote Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells, published in the journal Cancers.
	Harikrishna Nakshatri, Ph.D. (TMM), talked to Inside Indiana Business about the cancer center’s new translational cancer biology Ph.D. program.
	Tim Lautenschlaeger, M.D. (EDT), received a 2022 scientific grant from the Lung Cancer Research Foundation for his project, “24-hour urine based ctDNA analysis for early-stage NSCLC detection.” See the list of awardees.
	Lois Travis, M.D., Sc.D. (CPC), Patrick Monahan, Ph.D. (CPC), Kurt Kroenke, M.D., and colleagues wrote Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy, published in the Journal of Clinical Oncology.
	Thomas Imperiale, M.D., and colleagues conducted a study of online colorectal cancer risk calculators. Read the story.